SCHEMBL28658583

SCHEMBL28658583

[CH2]Cc1ccc(C(=O)NCc2ccc(Cl)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
CYP2C19 P33261 2/20 0.68
CYP1A2 P05177 1/20 0.68
RAB9A P51151 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
NAMPT P43490 1/20 0.59
EPHX2 P34913 2/20 0.58
PPARG P37231 2/20 0.58
CYP3A4 P08684 1/20 0.57
MAPK14 Q16539 1/20 0.57
TSHR P16473 1/20 0.56
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
TP53 P04637 1/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8987867 0.91 MEN1 (0.78) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL95043 0.90 MEN1 (0.68) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL2832296 0.85 MAPT (0.72) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL9119912 0.85 RAB9A (0.71) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL28648926 0.85 HDAC6 (0.70) RAB9AEPHX2PPARGTSHRPOLB
SCHEMBL5647805 0.83 MEN1 (0.68) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL25872270 0.83 MEN1 (0.72) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL13947380 0.83 MEN1 (0.72) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL19630500 0.83 MEN1 (0.72) MEN1KMT2ACYP2C19CYP1A2RAB9A
SCHEMBL6355362 0.83 POLB (0.72) MEN1KMT2ACYP2C19CYP1A2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026028-B Treatment of diabetes and metabolic syndrome with novel dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors 威斯康星州医药大学股份有限公司 2021-11-09 CN disclosed